152
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Human papillomavirus genotype distribution in genital warts among women in Harare-Zimbabwe

, ORCID Icon, , , , , & show all

References

  • Adler D, Wallace M, Bennie T, Abar B, Sadeghi R, Meiring T, et al. 2015. High risk human papillomavirus persistence among HIV-infected young women in South Africa. International Journal of Infectious Diseases 33:219–221.
  • Anic GM, Giuliano AR. 2011. Genital HPV infection and related lesions in men. Preventive Medicine [Online] 53 (Suppl 1): S36–S41.
  • Arron ST, Skewes-Cox P, Do PH, Dybbro E, Da Costa M, Palefsky JM, DeRisi JL. 2011. Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes. Journal of Nucleic Acids 2011:1–6. [cited 2016 Oct 31]. Available from: http://www.hindawi.com/journals/jna/2011/756905/abs/.
  • Aubin F, Prétet J-L, Jacquard A-C, Saunier M, Carcopino X, Jaroud F, EDiTH Study Group, et al. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: a large French National Study (EDiTH IV). Clinical Infectious Diseases 47:610–615.
  • Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjose S, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, et al. 2002. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. New England Journal of Medicine 346:1105–1112.
  • Chang L, Ci P, Shi J, Zhai K, Feng X, Colombara D, et al. 2013. Distribution of genital wart human papillomavirus genotypes in China: a multi-center study. Journal of Medical Virology 85:1765–1774.
  • Flagg EW, Torrone EA. 2018. Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006–2014. American Journal of Public Health 108:112–119.
  • Ginindza TG, Stefan CD, Tsoka-Gwegweni JM, Dlamini X, Jolly PE, Weiderpass E, et al. 2017. Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infectious Agents and Cancer 12:29.
  • Hartwig S, Baldauf J-J, Dominiak-Felden G, Simondon F, Alemany L, de Sanjosé S, Castellsagué X. 2015. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Research 1:90–100.
  • Hellner K, Dorrell L. 2017. Recent advances in understanding and preventing human papillomavirus-related disease [version 1; referees: 3 approved]. F1000Research 6:269. doi:10.12688/f1000research.9701.1.
  • Hernandez-Suarez G, Pineros M, Vargas JC, Orjuela L, Hernandez F, Peroza C, et al. 2013. Human papillomavirus genotypes in genital warts in Latin America: a cross-sectional study in Bogota, Colombia. International Journal of STD & AIDS 24:567–572.
  • Juelg E, Busch M, Lueger A, Guenova E, Schuetz-Bergmayr M, Hoetzenecker W. 2019. Distribution of human papillomavirus genotypes in condylomata acuminata: an Austrian cohort study. Dermatology 235:413–417. [cited 2019 Jul 23]. Available from: https://www.karger.com/Article/FullText/500908
  • Lacey CJN, Lowndes CM, Shah KV. 2006. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 24 (Suppl 3): S35–S41.
  • Lissouba P, Perre PVD, Auvert B. 2013. Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sexually Transmitted Infections 89:350–356.
  • Masciotra S, Luo W, Youngpairoj AS, Kennedy MS, Wells S, Ambrose K, et al. 2013. Performance of the Alere DetermineTM HIV-1/2 Ag/Ab combo rapid test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from ivory coast. Journal of Clinical Virology 58:e54–e58.
  • Neme S, Wahome E, Mwashigadi G, Thiong’o AN, Stekler JD, Wald A, et al. 2015. Prevalence, incidence, and clearance of anogenital warts in Kenyan men reporting high-risk sexual behavior, including men who have sex with men. Open Forum Infectious Diseases 2:ofv070. [cited 2015 May 12]. Available from: https://doi.org/10.1093/ofid/ofv070.
  • O’Mahony C, Gomberg M, Skerlev M, Alraddadi A, de las Heras‐Alonso ME, Majewski S, et al. 2019. Position statement for the diagnosis and management of anogenital warts. Journal of the European Academy of Dermatology and Venereology 33:1006–1019.
  • Palefsky JM. 2010. Human papillomavirus-related disease in men: not just a women’s issue. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine [Online] 46:S12–S19.
  • Patel H, Wagner M, Singhal P, Kothari S. 2013. Systematic review of the incidence and prevalence of genital warts. BMC Infectious Diseases 13:39.
  • Roden RBS, Stern PL. 2018. Opportunities and challenges for human papillomavirus vaccination in cancer. Nature Reviews Cancer 18:240–254.
  • Tayib S, Allan B, Williamson A-L, Denny L. 2015. Human papillomavirus genotypes and clinical management of genital warts in women attending a colposcopy clinic in Cape Town, South Africa. South African Medical Journal 105:679–684.
  • Van Aardt MC, Dreyer G, Snyman LC, Richter KL, Becker P, Mojaki SM. 2016. Oncogenic and incidental HPV types associated with histologically confirmed cervical intraepithelial neoplasia in HIV-positive and HIV-negative South African women. South African Medical Journal 106:617–622.
  • Wen LM, Estcourt CS, Simpson JM, Mindel A. 1999. Risk factors for the acquisition of genital warts: are condoms protective? Sexually Transmitted Infections 75:312–316.
  • Wigle J, Coast E, Watson-Jones D. 2013. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine 31:3811–3817.
  • Williamson A-L. 2015. The interaction between human immunodeficiency virus and human papillomaviruses in heterosexuals in Africa. Journal of Clinical Medicine 4:579–592.
  • Yew Y, Sen P, Chio T, Koay E, Chan R. 2013. P3.266 the prevalence of HPV genotypes in patients with genital warts in Singapore – will the HPV vaccine be useful in this population? Sexually Transmitted Infections 89:A231–A232.
  • Zhu C, Wang Y, Mao W, Zhang H, Ma J. 2019. Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study. BMJ Open [Online] 9: e023897.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.